BioPharm Asia, Inc (fka BFAR)

[VeryHolyGuy]

Stempro, market cap should reflect assets on hand and annual revenue. For example if assets and cash is 50 million and Liabilities is 25 million then the market cap should be around 25 million. Now you have to consider interest payments on loans. Minus this and add yearly net income and add this to the cash on hands should equate to the fair market value or market cap.

Clearly at the current market cap of 2.5 million, this stock is a steal and grossly undervalued. I see the market cap rising anywhere between 15 to 20 million short term which equates to .30 to .40 cents short term.